CR10862A - Metodo para determinar la estabilidad de metilenaminas organicas en presencia de amina oxidasa sensible a semicarbazida - Google Patents

Metodo para determinar la estabilidad de metilenaminas organicas en presencia de amina oxidasa sensible a semicarbazida

Info

Publication number
CR10862A
CR10862A CR10862A CR10862A CR10862A CR 10862 A CR10862 A CR 10862A CR 10862 A CR10862 A CR 10862A CR 10862 A CR10862 A CR 10862A CR 10862 A CR10862 A CR 10862A
Authority
CR
Costa Rica
Prior art keywords
stability
determining
sensitive
oxidase
semicarbazida
Prior art date
Application number
CR10862A
Other languages
English (en)
Inventor
Adedayo Adedoyin
Jennifer Cairns
Yongqing Huang
Guyan Liang
Heng-Keang Lim
Julie Ann Bick
Michael R Angelastro
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of CR10862A publication Critical patent/CR10862A/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/10Screening for compounds of potential therapeutic value involving cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invencion prporciona metodos para determinar la estabilidad de metilenamina, compuestos similares a metilenamina o compuestos que contienen un resto metilenamina en presencia de amina oxidase sensible a semicarbazida (SSAO) o una muestra biologica que contiene actividad de SSAO. Los metodos descritos se pueden configurar en un formato de ensayo para aplicaciones de seleccion de alto rendimiento.
CR10862A 2007-01-10 2009-06-11 Metodo para determinar la estabilidad de metilenaminas organicas en presencia de amina oxidasa sensible a semicarbazida CR10862A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88426307P 2007-01-10 2007-01-10

Publications (1)

Publication Number Publication Date
CR10862A true CR10862A (es) 2009-08-12

Family

ID=39361382

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10862A CR10862A (es) 2007-01-10 2009-06-11 Metodo para determinar la estabilidad de metilenaminas organicas en presencia de amina oxidasa sensible a semicarbazida

Country Status (29)

Country Link
US (3) US20100028895A1 (es)
EP (1) EP2121964A1 (es)
JP (2) JP2010515461A (es)
KR (1) KR20090107533A (es)
CN (1) CN101578375B (es)
AR (1) AR064776A1 (es)
AU (1) AU2008204923A1 (es)
BR (1) BRPI0806321A2 (es)
CA (1) CA2674704A1 (es)
CR (1) CR10862A (es)
DO (1) DOP2009000175A (es)
EC (1) ECSP099507A (es)
GT (1) GT200900199A (es)
HN (1) HN2009001289A (es)
IL (1) IL199707A0 (es)
MA (1) MA31226B1 (es)
MX (1) MX2009005962A (es)
MY (1) MY152893A (es)
NI (1) NI200900132A (es)
NO (1) NO20092816L (es)
NZ (1) NZ578079A (es)
RU (1) RU2009130380A (es)
SG (1) SG177920A1 (es)
SV (1) SV2009003327A (es)
TN (1) TN2009000232A1 (es)
TW (1) TW200907065A (es)
UA (1) UA103300C2 (es)
WO (1) WO2008086325A1 (es)
ZA (1) ZA200903897B (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100533911B1 (ko) 1997-05-23 2005-12-06 바이오티에 세라피스 코포레이션 아민 산화효소의 활성을 갖는 혈관 점착 단백질-1
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
JP4499918B2 (ja) * 1998-03-27 2010-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高スループット・スクリーニング用の小型化マイクロタイタ・プレート
GB0012362D0 (en) * 2000-05-22 2000-07-12 Aventis Pharma Ltd Chemical compounds
EP1362120A1 (en) 2001-02-23 2003-11-19 Biovitrum Ab Method for purification of soluble ssao

Also Published As

Publication number Publication date
MY152893A (en) 2014-11-28
MX2009005962A (es) 2009-06-15
AU2008204923A1 (en) 2008-07-17
HK1137784A1 (en) 2010-08-06
TW200907065A (en) 2009-02-16
EP2121964A1 (en) 2009-11-25
BRPI0806321A2 (pt) 2011-09-06
KR20090107533A (ko) 2009-10-13
US20130071870A1 (en) 2013-03-21
TN2009000232A1 (en) 2010-10-18
MA31226B1 (fr) 2010-03-01
GT200900199A (es) 2010-04-13
NO20092816L (no) 2009-08-10
WO2008086325A1 (en) 2008-07-17
SV2009003327A (es) 2010-02-05
RU2009130380A (ru) 2011-02-20
JP2014204727A (ja) 2014-10-30
WO2008086325A8 (en) 2009-07-16
NI200900132A (es) 2010-03-01
AR064776A1 (es) 2009-04-22
US20100028895A1 (en) 2010-02-04
US8883410B2 (en) 2014-11-11
JP2010515461A (ja) 2010-05-13
HN2009001289A (es) 2013-02-11
UA103300C2 (ru) 2013-10-10
NZ578079A (en) 2013-02-22
IL199707A0 (en) 2010-04-15
US20140363836A1 (en) 2014-12-11
DOP2009000175A (es) 2009-07-31
CN101578375B (zh) 2012-11-07
CN101578375A (zh) 2009-11-11
SG177920A1 (en) 2012-02-28
ZA200903897B (en) 2010-04-28
ECSP099507A (es) 2009-08-28
CA2674704A1 (en) 2008-07-17

Similar Documents

Publication Publication Date Title
BRPI0710054B8 (pt) métodos para identificar um ou uma pluralidade de metabólitos celulares, para triar um composto de teste, e, para testar um composto de teste
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
CR10612A (es) Anticuerpo especifico prlr y sus usos
EP4249605A3 (en) Methods for analyte detection
CL2012003104A1 (es) Compuestos derivados de multiheteroarilos, inhibidores de prostaglandina d sintasa hematopoyetica (h-pgds); y composicion farmaceutica que los comprende.
BRPI0513897A (pt) diferenciação de células-tronco
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
AR053251A1 (es) Estrategias nuevas de etiquetado para la deteccion sensible de analitos
ES2674177T3 (es) Preparación de suero
BRPI0907656A2 (pt) composto para testar a pureza de cisatracúrio, método para testar a pureza de uma amostra de besilato de cisatracúrio, uso de um composto para testar a pureza de cisatracúrio e processo para preparar compostos para testar a pureza de cisatracúrio
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
CL2009001488A1 (es) Metodo para tratar una muestra liquida que contiene particulas microbiologicas.
DE602006008639D1 (de) Automatisches radioaktives markierungsverafhren
MX2012000041A (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
CR10862A (es) Metodo para determinar la estabilidad de metilenaminas organicas en presencia de amina oxidasa sensible a semicarbazida
AR064467A1 (es) Derivados de antraquinona como sustancias marcadoras para liquidos
BR112016006955A2 (pt) compostos de marcação e seu uso em ensaios
ATE514082T1 (de) Biologischer bodendetektor
CL2011003313A1 (es) Metodo de replicacion, amplificacion o secuenciacion de un adn molde que comprende poner en contacto dicho adn con una mezcla de reaccion; kit para reaccion antes mencionada.
UY29918A1 (es) Reactivo para sensores de prueba que contiene polimeros de celulosa
HN2011001773A (es) Compuestos etanaminicos y su uso para tratar la depresion nuevo titulo técnico: compuestos etanamínicos y composición farmacéutica que los contiene para la depresion. (a petición de la oficina)
HK1216258A1 (zh) 作用於多巴胺能神经元上的制剂的快速筛查
ATE556321T1 (de) Analyse des gpcr-signalweges mit biosensor- zelltests
TNSN07428A1 (en) Method
DE602006018071D1 (de) Automatische detektion eines gps-sa-basiswerts für hfom

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)